SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 53.57-3.1%10:28 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (6502)6/7/2002 10:22:52 AM
From: aknahow  Read Replies (1) of 52153
 
Had expected FDA decision on Amevive to clear the air one way or the other. But BGEN now says it has always said approval is expected at year end or first quarter 2003.

So, I no longer think movement in biotech stocks will drift until an August FDA Amevive decision. Year end is too far away of an event to influence the entire sector, until then.

Some other seminal event will be needed to cause a rally or wash out decline. Thought it would be final word on Amevive but apparently not.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News